epitalon and ghk-cu is ghk cu a copper peptide Epitalon/Epithalon peptide epitalon and ghk cu together

The top dose produced 20.9% average weight loss over 72 weeks and 20.2% in a direct comparison with semaglutides 13.7%. Its second receptor, GIP, separates tirzepatide from approved single-receptor GLP-1 drugs and helps explain the larger population-level weight loss. That 20.9% came from participants averaging about 105 kg at a BMI of 38, most of whom were sedentary

Store the mixed vial at 4 C and use within 28 days

Chronic daily treatment with acyl-GIP reduced body weight and food intake in control DIO Gipr AP-GFP mice, associated with a significant reduction in fat mass

Possible side effects may include mild gastrointestinal discomfort, headache, or temporary flushing, depending on the method of delivery

PubMed , Biomedicines , vol